Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

Abstract

The apparent high prevalence of T-cell and NK-cell lymphomas in the Chinese was due to more frequent NK-cell but not T-cell lymphomas.

Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma

“…Although NK-cell lymphoma is prevalent in Asians, 15 primary intestinal NK-cell lymphoma is extremely rare and highly aggressive, with short survival times. Most primary intestinal NK-cell lymphoma patients in our study were middle-aged Figure 2 Kaplan-Meier survival curves and log-rank test for cumulative survival of the NK-cell group and the T-cell group are shown.…”

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

“…The treatment outcomes of extranodal NK/T-cell lymphoma have not been satisfactory, 1,2 even in the cases with localized disease. 3 The prior therapeutic approach with radiotherapy alone for localized disease showed frequent systemic failure, 4,5 which has led to searching for efficient combination modality treatment with chemotherapy and radiotherapy.…”

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T‐cell lymphoma, nasal type: a multicenter trial in Northwest China

“…Extranodal natural killer/T‐cell lymphoma (NKTCL), nasal type, is a distinct and heterogeneous histopathologic subtype of non‐Hodgkin lymphoma (NHL), accounting for 5% to 10% of cases 1, 2, 3. The frequency of NKTCL among patients with NHL is significantly higher in Asia than in Europe and North America 4, 5, 6, 7.…”